XIX INTERNATIONAL SCHOOL OF PHARMACOLOGY «TEÓFILO HERNANDO». ADVANCED THERAPIES FOR HUMAN DISEASE

Sede donde se gestiona

Santander

Lugar de impartición

Santander – Península de la Magdalena

Dirección

Michael Duchen
University College London, UK

Antonio G. García
Universidad Autónoma de Madrid, Spain

Secretaría

Luis Gandía Juan
Universidad Autónoma de Madrid, Spain

ORGANIZADO EN COLABORACIÓN CON

Fundación Teófilo Hernando

Descripción de la actividad

Central stage in the fascinating field of drug discovery and development is the identification of drugable targets implicated in the pathogenesis of a given human disease. Hence, in this School frontier knowledge in such endeavour will be analysed by worldwide renowned scientists in the field of neuroscience, mitochondria, the epilepsies, Alzheimer´s disease, cell therapies and other advanced therapies. This XIX edition of the International Teófilo Hernando’s Pharmacology School will enlighten young PhD and postdoctoral students, as well as graduate students in the area of biomedical sciences. Additionally, PhD and postdoctoral students will have the opportunity of presenting their work to the class and professors. It is a tradition in this School that professors and students read a poem to the class dealing with their own culture. In doing so, humanities and science walk hand in hand, as in renaissance times, 500 years ago. Hence, the School is a science and humanistic unique experience that reminds the foundation of UIMP by poets and scientists near 100 years ago.

 

The International Pharmacology School “Teófilo Hernando” was initiated in 1996, in the frame of the summer courses of UIMP. At that time, Rector José Luis García Delgado invited professor Antonio G. García (Universidad Autónoma de Madrid) to organise this School.

 

The School was named after Teófilo Hernando, a Spanish MD/PhD pharmacologist who was trained under Oswald Schmiedeberg at Strassbourg, the first formal Pharmacology School where many pharmacologists throughout the word were trained at the end of the XIX century and the beginning of the XX century and then developed the subject of basic and clinical pharmacology in their own countries. Teófilo Hernando introduced pharmacology as an independent teaching and science subject at the Universidad Complutense de Madrid, along the first three decades of the XX century this academic matter soon spread out to several Spanish universities by pharmacologists trained under professor Hernando. He trained numerous other disciples that extended the subject to many other Spanish universities along the XX century.

 

The format of a UIMP’s School (“Escuela”) is based in the critical analysis in the frontier of knowledge of a given scientific topic, along a week (Monday to Friday) by scientists and students of all over the world. Two sessions are delivered in the morning by invited scientists, lasting each one two hours, with vivid discussions. In the afternoon, PhD students and postdocs present their ongoing scientific work as short oral communications. Emphasis is always made in the identification of new biological drug targets that illuminate the design, synthesis and development of new medicines to treat human diseases.

Participantes

DIRECCIÓN

Michael Duchen
University College London, UK
Antonio G. García
Universidad Autónoma de Madrid, Spain

SECRETARÍA

Luis Gandía Juan
Universidad Autónoma de Madrid, Spain

PARTICIPANTES

Katherine Benson
Royal College of Surgeons in Ireland, Ireland
María A. Blasco
Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
Francesco di Virgilio
University of Ferrara, Ferrara, Italy
Tobias Engel
Royal College of Surgeons in Ireland, Dublin, Ireland
José Alberto López Domínguez
Institute for Research in Biomedicine, Barcelona, Spain
Francesco Saverio Tedesco
University College London, UK
Natalie Yivgi-Ohana
MINOVIA, Israel
Rafael Yuste
Columbia University, New York, USA

Programa

Lunes, 20 Junio 2022

10:00
School inauguration by directors and UIMP academic authority
10:30
Senolytic therapies in cancer and other diseases
José Alberto López Domínguez
12:00
Telomers and telomerase in cancer and ageing
María A. Blasco
15:00
Young Researcher Presentations (YRP-1)
Coordinator
Luis Gandía Juan

Martes, 21 Junio 2022

10:00
Mitochondrial pathways as therapeutic targets for human disease
Michael Duchen
12:00
Mitochondrial cell therapy
Natalie Yivgi-Ohana
15:00
Young Researcher Presentations (YRP-2)
Coordinator
Luis Gandía Juan

Miércoles, 22 Junio 2022

10:00
Reprogramming human skeletal muscle regeneration: new strategies for neuromuscular modelling and therapy
Francesco Saverio Tedesco
12:00
Neurodegeneration, neuroprotection and drug repositioning
Antonio G. García
15:00
Young Researcher Presentations (YRP-3)
Coordinator
Luis Gandía Juan

Jueves, 23 Junio 2022

10:00
Targeting mRNA polyadenylation as a novel therapeutic approach to treat drug refractory epilepsy
Tobias Engel
12:00
Epilepsy as a model for precision therapeutics
Katherine Benson
15:00
Young Researcher Presentations (YRP-4)
Coordinator
Luis Gandía Juan

Viernes, 24 Junio 2022

10:00
Targeting purinergic check-points in inflammation and cancer
Francesco di Virgilio
12:00
Closing lecture
The novel neurotechnologies: implication for science and medicine
Rafael Yuste
13:00
Closing ceremony
Michael Duchen
Antonio G. García

Descubre todos los cursos en abierto de la edición de 2022